OC.11.2 RAFOXANIDE INHIBITS EPITHELIAL STAT3 ACTIVATION AND STAT3-DRIVEN ONCOGENIC IMMUNE RESPONSE IN THE COLORECTAL CANCER MICROENVIRONMENT. (March 2023) - Pacifico, T.; Laudisi, F.; Franze, E.; Maresca, C.; Luiz-Ferreira, A.; Tomassini, L.; Ortenzi, A.; Colantoni, A.; Sica, G.S.; Monteleone, I.; Monteleone, G.; Stolfi, C.